Advances in systemic therapies for triple negative breast cancer.
Leon-Ferre RA, Goetz MP.
BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674.
Consensus, debate, and prospective on pancreatic cancer treatments.
Wang J, Yang J, Narang A, He J, Wolfgang C, Li K, Zheng L.
J Hematol Oncol. 2024 Oct 10;17(1):92. doi: 10.1186/s13045-024-01613-x.
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.
Galant N, Krawczyk P, Monist M, Obara A, Gajek Ł, Grenda A, Nicoś M, Kalinka E, Milanowski J.
Int J Mol Sci. 2024 May 28;25(11):5893. doi: 10.3390/ijms25115893.
Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
Wang JB, Gao YX, Ye YH, Zheng QL, Luo HY, Wang SH, Zhang T, Jin QW, Zheng CH, Li P, Lin JX, Chen QY, Cao LL, Yang YH, Huang CM, Xie JW.
Theranostics. 2024 May 5;14(7):2915-2933. doi: 10.7150/thno.93124. eCollection 2024.
Immunosurveillance in clinical cancer management.
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L.
CA Cancer J Clin. 2024 Mar-Apr;74(2):187-202. doi: 10.3322/caac.21818. Epub 2023 Oct 25.
Association of Neoadjuvant Immunotherapy With Postoperative Major Morbidity After Oncologic Surgery.
Habib DRS, Shou M, Philips RH, Pickens A, Hawkins AT, Idrees K, Khan A.
Ann Surg Oncol. 2024 Dec;31(13):8508-8513. doi: 10.1245/s10434-024-16284-8. Epub 2024 Sep 28.
Current and Future Treatment Options in the Management of Stage III NSCLC.
Li Y, Juergens RA, Finley C, Swaminath A.
J Thorac Oncol. 2023 Nov;18(11):1478-1491. doi: 10.1016/j.jtho.2023.08.011. Epub 2023 Aug 11.
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy.
Bai G, Chen X, Peng Y, Ji Y, Bie F, Liu Y, Yang Z, Gao S.
Thorac Cancer. 2024 May;15(14):1138-1148. doi: 10.1111/1759-7714.15297. Epub 2024 Apr 4.
Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
Czarnecka AM, Ostaszewski K, Błoński P, Szumera-Ciećkiewicz A, Kozak K, Placzke J, Borkowska A, Terlecka A, Rogala P, Świtaj T, Sałamacha M, Mitręga-Korab B, Krotewicz M, Dudzisz-Śledź M, Rutkowski P.
Eur J Surg Oncol. 2024 Jul;50(7):108382. doi: 10.1016/j.ejso.2024.108382. Epub 2024 May 14.
Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment.
Chu X, Mi B, Xiong Y, Wang R, Liu T, Hu L, Yan C, Zeng R, Lin J, Fu H, Liu G, Zhang K, Bian L.
Biomaterials. 2025 Jan;312:122714. doi: 10.1016/j.biomaterials.2024.122714. Epub 2024 Jul 27.
